BioCentury
ARTICLE | Company News

GlaxoSmithKline, NIH deal

July 11, 2016 7:00 AM UTC

GlaxoSmithKline and NIH’s Vaccine Research Center partnered to conduct laboratory studies of a Zika vaccine using the pharma’s self-amplifying mRNA (SAM) technology, which the pharma said could lead t...